AAN: Antidepressants Not Tied to Increased Intracerebral Hemorrhage Risk
WEDNESDAY, March 3, 2021 -- Antidepressant use is not associated with an increased rate of intracerebral hemorrhage (ICH), according to a study scheduled for presentation at the upcoming annual meeting of the American Academy of Neurology, to be held virtually from April 17 to 22.
Mithilesh Siddu, M.D., from the University of Miami, and colleagues used the Florida Stroke Registry to identify 127,915 ICH cases with antidepressant use data available.
The researchers found that the rate of ICH among prior antidepressant users (17,009 patients; median age, 74 years) was 11 percent compared with 14 percent in antidepressant nonusers (110,906 patients; median age, 72 years). When adjusting for age, race, prior history of hypertension, diabetes, and oral anticoagulant, antiplatelet, and statin use, antidepressant users were just as likely to present with spontaneous ICH as nonusers (odds ratio, 0.92; 95 percent confidence interval, 0.85 to 1.01). A total of 3.4 percent of all ICH patients and 9 percent of those in whom antidepressant information was available were discharged home on an antidepressant (74 percent selective serotonin reuptake inhibitor and 24 percent other antidepressant).
"These findings are important, especially since depression is common after stroke and selective serotonin reuptake inhibitors are some of the first drugs considered for people," Siddu said in a statement. "More research is needed to confirm our findings and to also examine if selective serotonin reuptake inhibitors prescribed after a stroke may be linked to risk of a second stroke."
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
FRIDAY, April 16, 2021 -- People with a severe mental illness (SMI) are more likely to die following a heart attack than those without a psychiatric diagnosis, according to a...
FRIDAY, April 16, 2021 -- COVID-19 ups the risk for death with hemorrhagic stroke by more than twofold, according to a study published online April 14 in PLOS ONE. Vijay M....
THURSDAY, April 15, 2021 -- For patients with major depressive disorder, the change in scores for depression at six weeks does not differ significantly with psilocybin or...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.